Can Human Papillomavirus DNA Self-sampling be an Acceptable and Reliable Option for Cervical Cancer Screening in Female Sex Workers?

被引:12
|
作者
Wong, Eliza L. Y. [1 ]
Cheung, Annie W. L. [1 ]
Huang, Fenwei [1 ]
Chor, Josette S. Y. [1 ]
机构
[1] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China
关键词
Acceptability; Cervical cancer screening; HPV DNA self-sampling; Reliability; Underscreened population group; HONG-KONG; COST-EFFECTIVENESS; PAP TEST; HPV; WOMEN; METAANALYSIS; HEALTH; PREVENTION; SPECIMENS; LESIONS;
D O I
10.1097/NCC.0000000000000462
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The causal relation between human papillomavirus (HPV) and cervical cancer has enabled HPV self-sampling to be envisaged as a possible screening method. Objectives: The aim of this study is to explore the acceptability and reliability of HPV DNA self-sampling as an alternative option for cervical screening among female sex workers. Methods: Sixty-eight participants carried out self-sampling for HPV testing, gave a clinician-obtained sample for HPV testing, and a Papanicolaou test. After the samplings, the participants were questioned on the acceptability of the tests. Results: Most participants (65.6%) preferred to adopt HPV DNA self-sampling in the future; in particular, those without previous experience of Papanicolaou tests marginally significantly preferred self-sampling (86.7%, P = .055). The overall crude agreement in HPV detection rates between clinician and HPV DNA self-sampling was 85.3% (58/68), with a of 0.69 (95% confidence interval, 0.51-0.87). The sensitivity and specificity of self-collected samples were 66.7% and 66.1%, respectively, and the positive and negative predicted values were 24.0% and 92.5%, respectively. The prevalence of HPV was slightly higher in self-collected samples (39.7%, 27/68) than in clinician-collected samples (36.8%, 25/68). The participants expressed positive attitudes toward self-sampling but were less confident in their skills of self-sampling compared with clinicians (70.6% versus 91.2%). Conclusions: The findings showed that self-sampling could be incorporated into current cervical cancer screening approaches. Implications for Practice: Self-sampling could potentially increase compliance to cervical cancer screening and thus reduce the morbidity and mortality from cervical cancer. Further research and education on self-sampling will be required for women of diverse backgrounds.
引用
收藏
页码:45 / 52
页数:8
相关论文
共 50 条
  • [1] Evaluation of the Impact of Human Papillomavirus DNA Self-sampling on the Uptake of Cervical Cancer Screening
    Wong, Eliza L. Y.
    Chan, Paul K. S.
    Chor, Josette S. Y.
    Cheung, Annie W. L.
    Huang, Fenwei
    Wong, Samuel Y. S.
    CANCER NURSING, 2016, 39 (01) : E1 - E11
  • [2] Preferred Location for Human Papillomavirus Self-Sampling for Cervical Cancer Screening
    Liebermann, Erica
    Fontenot, Holly B.
    Lim, Eunjung
    Matsunaga, Masako
    Zimet, Gregory
    Allen, Jennifer D.
    JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING, 2023, 52 (05): : 364 - 373
  • [3] Acceptability of Self-Sampling for Human Papillomavirus-Based Cervical Cancer Screening
    Chatzistamatiou, Kimon
    Vrekoussis, Thomas
    Tsertanidou, Athena
    Moysiadis, Theodoros
    Mouchtaropoulou, Evangelia
    Pasentsis, Konstantinos
    Kitsou, Anastasia
    Moschaki, Viktoria
    Ntoula, Maria
    Zempili, Paraskevi
    Halatsi, Despina
    Truva, Theoni
    Piha, Vaia
    Agelena, Georgia
    Daponte, Alexandros
    Vanakara, Polyxeni
    Paschopoulos, Minas
    Stefos, Theodoros
    Lymberis, Vasilis
    Kontomanolis, Emmanuel N.
    Makrigiannakis, Antonis
    Deligeoroglou, Efthimios
    Panoskaltsis, Theodoros
    Adonakis, George
    Michail, George
    Stamatopoulos, Kostas
    Agorastos, Theodoros
    JOURNAL OF WOMENS HEALTH, 2020, 29 (11) : 1447 - 1456
  • [4] Primary cervical cancer screening by self-sampling of human papillomavirus DNA in internal medicine outpatient clinics
    Dannecker, C
    Siebert, U
    Thaler, CJ
    Kiermeir, D
    Hepp, H
    Hillemanns, P
    ANNALS OF ONCOLOGY, 2004, 15 (06) : 863 - 869
  • [5] Self-sampling for human papillomavirus (HPV) testing as cervical cancer screening option.: Experience from the LAMS Study
    Longatto-Filho, A.
    Roteli-Martins, C.
    Hammes, L.
    Etlinger, D.
    Pereira, S. M. Miranda
    Erzen, M.
    Branca, M.
    Naud, P.
    Derchain, S. F. M.
    Sarian, L. O.
    Matos, J.
    Gontijo, R.
    Lima, T.
    Maeda, M. Y. S.
    Tatti, S.
    Syrjanen, S.
    Syrjanen, K.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2008, 29 (04) : 327 - 332
  • [6] Self-sampling for high-risk human papillomavirus detection: future cervical cancer screening?
    Daponte, Alexandros
    Pournaras, Spyros
    Tsakris, Athanassios
    WOMENS HEALTH, 2014, 10 (02) : 115 - 118
  • [7] Challenges in the Implementation of Human Papillomavirus Self-Sampling for Cervical Cancer Screening in India: A Systematic Review
    Hariprasad, Roopa
    John, Amrita
    Abdulkader, Rizwan Suliankatchi
    JCO GLOBAL ONCOLOGY, 2023, 9 : e2200401
  • [8] Cervical Cancer Screening with Human Papillomavirus Self-Sampling Among Transgender Men in El Salvador
    Maza, Mauricio
    Melendez, Mario
    Herrera, Alejandra
    Hernandez, Xavier
    Rodriguez, Bryan
    Soler, Montserrat
    Alfaro, Karla
    Masch, Rachel
    Conzuelo-Rodriguez, Gabriel
    Obedin-Maliver, Juno
    Cremer, Miriam
    LGBT HEALTH, 2020, 7 (04) : 174 - 181
  • [9] Determinants for Participation in Human Papillomavirus Self-Sampling among Nonattenders to Cervical Cancer Screening in Denmark
    Harder, Elise
    Thomsen, Louise T.
    Hertzum-Larsen, Rasmus
    Albieri, Vanna
    Hessner, Marie Vik
    Juul, Kirsten Egebjerg
    Bonde, Jesper
    Frederiksen, Kirsten
    Kjaer, Susanne K.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (11) : 1342 - 1351
  • [10] Human Papillomavirus Types and Cervical Cancer Screening among Female Sex Workers in Cameroon
    Manga, Simon M.
    Ye, Yuanfan
    Nulah, Kathleen L.
    Manjuh, Florence
    Fokom-Domgue, Joel
    Scarinci, Isabel
    Tita, Alan N.
    CANCERS, 2024, 16 (02)